Evidence of cerebellar TDP-43 loss of function in FTLD-TDP

被引:0
|
作者
Sarah Pickles
Tania F. Gendron
Yuka Koike
Mei Yue
Yuping Song
Jennifer M. Kachergus
J. Shi
Michael DeTure
E. Aubrey Thompson
Björn Oskarsson
Neill R. Graff-Radford
Bradley F. Boeve
Ronald C. Petersen
Zbigniew K. Wszolek
Keith A. Josephs
Dennis W. Dickson
Leonard Petrucelli
Casey N. Cook
Mercedes Prudencio
机构
[1] Mayo Clinic,Department of Neuroscience
[2] Mayo Clinic Graduate School of Biomedical Sciences,Department of Cancer Biology
[3] Mayo Clinic,Department of Neurology
[4] Mayo Clinic,Department of Neurology
[5] Mayo Clinic,undefined
关键词
Cerebellum; Frontotemporal lobar degeneration; Stathmin-2; TDP-43;
D O I
暂无
中图分类号
学科分类号
摘要
Frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) is a neurodegenerative disease primarily affecting the frontal and/or temporal cortices. However, a growing body of evidence suggests that the cerebellum contributes to biochemical, cognitive, and behavioral changes in FTLD-TDP. To evaluate cerebellar TDP-43 expression and function in FTLD-TDP, we analyzed TDP-43 protein levels and the splicing of a TDP-43 target, STMN2, in the cerebellum of 95 FTLD-TDP cases and 25 non-neurological disease controls. Soluble TDP-43 was decreased in the cerebellum of FTLD-TDP cases but a concomitant increase in insoluble TDP-43 was not seen. Truncated STMN2 transcripts, an indicator of TDP-43 dysfunction, were elevated in the cerebellum of FTLD-TDP cases and inversely associated with TDP-43 levels. Additionally, lower cerebellar TDP-43 associated with a younger age at disease onset. We provide evidence of TDP-43 loss of function in the cerebellum in FTLD-TDP, supporting further investigation into this understudied brain region.
引用
收藏
相关论文
共 50 条
  • [1] Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
    Pickles, Sarah
    Gendron, Tania F.
    Koike, Yuka
    Yue, Mei
    Song, Yuping
    Kachergus, Jennifer M.
    Shi, J.
    DeTure, Michael
    Thompson, E. Aubrey
    Oskarsson, Bjorn
    Graff-Radford, Neill R.
    Boeve, Bradley F.
    Petersen, Ronald C.
    Wszolek, Zbigniew K.
    Josephs, Keith A.
    Dickson, Dennis W.
    Petrucelli, Leonard
    Cook, Casey N.
    Prudencio, Mercedes
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [2] TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
    Arseni, Diana
    Chen, Renren
    Murzin, Alexey G.
    Peak-Chew, Sew Y.
    Garringer, Holly J.
    Newell, Kathy L.
    Kametani, Fuyuki
    Robinson, Andrew C.
    Vidal, Ruben
    Ghetti, Bernardino
    Hasegawa, Masato
    Ryskeldi-Falcon, Benjamin
    NATURE, 2023, 620 (7975) : 898 - 903
  • [3] Mechanisms of Disease in FTLD - TDP-43 loss of function
    Cairns, Nigel J.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 33 : 3 - 4
  • [4] Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes
    Yasushi Nishihira
    Tamar Gefen
    Qinwen Mao
    Christina Appin
    Missia Kohler
    Jamie Walker
    Rosa Rademakers
    Alfred Rademaker
    Emily Rogalski
    Sandra Weintraub
    Changiz Geula
    M-Marsel Mesulam
    Eileen H. Bigio
    Acta Neuropathologica, 2019, 138 : 167 - 169
  • [5] Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes
    Nishihira, Yasushi
    Gefen, Tamar
    Mao, Qinwen
    Appin, Christina
    Kohler, Missia
    Walker, Jamie
    Rademakers, Rosa
    Rademaker, Alfred
    Rogalski, Emily
    Weintraub, Sandra
    Geula, Changiz
    Mesulam, M-Marsel
    Bigio, Eileen H.
    ACTA NEUROPATHOLOGICA, 2019, 138 (01) : 167 - 169
  • [6] TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP
    Diana Arseni
    Renren Chen
    Alexey G. Murzin
    Sew Y. Peak-Chew
    Holly J. Garringer
    Kathy L. Newell
    Fuyuki Kametani
    Andrew C. Robinson
    Ruben Vidal
    Bernardino Ghetti
    Masato Hasegawa
    Benjamin Ryskeldi-Falcon
    Nature, 2023, 620 : 898 - 903
  • [7] Differential detection of TDP-43 in FTLD-TDP Type C using antibodies targeting distinct TDP-43 phosphorylated sites
    Cracco, L.
    Jacobsen, M.
    Hallinan, G.
    Garringer, H.
    Buratti, E.
    Ghetti, B.
    Newell, K.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024, 83 (06): : 437 - 437
  • [8] Antibody against TDP-43 phosphorylated at serine 375 suggests conformational differences of TDP-43 aggregates among FTLD-TDP subtypes
    Neumann, Manuela
    Frick, Petra
    Paron, Francesca
    Kosten, Jonas
    Buratti, Emanuele
    Mackenzie, Ian R.
    ACTA NEUROPATHOLOGICA, 2020, 140 (05) : 645 - 658
  • [9] Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
    Yi Xiao Jiang
    Qin Cao
    Michael R. Sawaya
    Romany Abskharon
    Peng Ge
    Michael DeTure
    Dennis W. Dickson
    Janine Y. Fu
    Rachel R. Ogorzalek Loo
    Joseph A. Loo
    David S. Eisenberg
    Nature, 2022, 605 : 304 - 309
  • [10] Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43
    Jiang, Yi Xiao
    Cao, Qin
    Sawaya, Michael R.
    Abskharon, Romany
    Ge, Peng
    DeTure, Michael
    Dickson, Dennis W.
    Fu, Janine Y.
    Loo, Rachel R. Ogorzalek
    Loo, Joseph A.
    Eisenberg, David S.
    NATURE, 2022, 605 (7909) : 304 - +